ID:EIF2A_HUMAN DESCRIPTION: RecName: Full=Eukaryotic translation initiation factor 2A; Short=eIF-2A; AltName: Full=65 kDa eukaryotic translation initiation factor 2A; FUNCTION: Functions in the early steps of protein synthesis of a small number of specific mRNAs. Acts by directing the binding of methionyl-tRNAi to 40S ribosomal subunits. In contrast to the eIF- 2 complex, it binds methionyl-tRNAi to 40 S subunits in a codon- dependent manner, whereas the eIF-2 complex binds methionyl-tRNAi to 40 S subunits in a GTP-dependent manner. May act by impiging the expression of specific proteins. TISSUE SPECIFICITY: Widely expressed. Expressed at higher level in pancreas, heart, brain and placenta. SIMILARITY: Belongs to the WD repeat EIF2A family. SIMILARITY: Contains 3 WD repeats. CAUTION: Was initially thought to constitute the ortholog of prokaryotic IF-2 (infB) protein. SEQUENCE CAUTION: Sequence=AAK14926.1; Type=Erroneous initiation; Sequence=AAM83402.1; Type=Frameshift; Positions=82, 90; Sequence=AAQ13506.1; Type=Frameshift; Positions=513; Sequence=AAQ13612.1; Type=Erroneous initiation;
The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.
ModBase Predicted Comparative 3D Structure on Q9BY44
Front
Top
Side
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.
Orthologous Genes in Other Species
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
AF212241 - Homo sapiens CDA02 mRNA, complete cds. AK298586 - Homo sapiens cDNA FLJ58035 complete cds, highly similar to Homo sapiens eukaryotic translation initiation factor (eIF) 2A (eIF2A), mRNA. AK293993 - Homo sapiens cDNA FLJ57962 complete cds, highly similar to Homo sapiens eukaryotic translation initiation factor (eIF) 2A (eIF2A), mRNA. AK027356 - Homo sapiens cDNA FLJ14450 fis, clone HEMBB1001736, weakly similar to EUKARYOTIC TRANSLATION INITIATION FACTOR 3 SUBUNIT 9. BX647951 - Homo sapiens mRNA; cDNA DKFZp686F2451 (from clone DKFZp686F2451). AL833101 - Homo sapiens mRNA; cDNA DKFZp313E0915 (from clone DKFZp313E0915). BC011885 - Homo sapiens eukaryotic translation initiation factor 2A, 65kDa, mRNA (cDNA clone MGC:20557 IMAGE:3688407), complete cds. AF497978 - Homo sapiens eukaryotic translation initiation factor 2A mRNA, complete cds. AB590213 - Synthetic construct DNA, clone: pFN21AE1363, Homo sapiens EIF2A gene for eukaryotic translation initiation factor 2A, 65kDa, without stop codon, in Flexi system. DQ896788 - Synthetic construct Homo sapiens clone IMAGE:100011248; FLH199407.01L; RZPDo839E0981D eukaryotic translation initiation factor 2A, 65kDa (EIF2A) gene, encodes complete protein. EU176412 - Synthetic construct Homo sapiens clone IMAGE:100006536; FLH197109.01X; RZPDo839C05252D eukaryotic translation initiation factor 2A, 65kDa (EIF2A) gene, encodes complete protein. AF172818 - Homo sapiens MSTP089 (MST089) mRNA, complete cds. AF109358 - Homo sapiens MSTP004 mRNA, complete cds. JD357562 - Sequence 338586 from Patent EP1572962. JD312741 - Sequence 293765 from Patent EP1572962. JD225946 - Sequence 206970 from Patent EP1572962. JD171398 - Sequence 152422 from Patent EP1572962. JD197778 - Sequence 178802 from Patent EP1572962. JD412734 - Sequence 393758 from Patent EP1572962. JD512688 - Sequence 493712 from Patent EP1572962. JD340672 - Sequence 321696 from Patent EP1572962. JD499634 - Sequence 480658 from Patent EP1572962. JD286634 - Sequence 267658 from Patent EP1572962. JD511477 - Sequence 492501 from Patent EP1572962. JD564345 - Sequence 545369 from Patent EP1572962. JD558275 - Sequence 539299 from Patent EP1572962. JD319354 - Sequence 300378 from Patent EP1572962. JD223320 - Sequence 204344 from Patent EP1572962. JD225092 - Sequence 206116 from Patent EP1572962. JD506403 - Sequence 487427 from Patent EP1572962. JD061174 - Sequence 42198 from Patent EP1572962. JD162366 - Sequence 143390 from Patent EP1572962. JD282061 - Sequence 263085 from Patent EP1572962. JD230257 - Sequence 211281 from Patent EP1572962. JD270176 - Sequence 251200 from Patent EP1572962.
Biochemical and Signaling Pathways
BioCarta from NCI Cancer Genome Anatomy Project h_chemicalPathway - Apoptotic Signaling in Response to DNA Damage h_igf1mtorpathway - Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway h_eifPathway - Eukaryotic protein translation h_rnaPathway - Double Stranded RNA Induced Gene Expression h_vegfPathway - VEGF, Hypoxia, and Angiogenesis h_eif2Pathway - Regulation of eIF2